Intellia Therapeutics, Inc. (NTLA) vs Pacific Biosciences of Californ (PACB)
Detailed comparison between Intellia Therapeutics, Inc., Pacific Biosciences of Californ.Total Return (%)
Intellia Therapeutics, Inc. (NTLA)Pacific Biosciences of Californ (PACB)
Which stock do you think will perform better?
Intellia Therapeutics, Inc.
NTLA
Pacific Biosciences of Californ
PACB
| Metric | Intellia Therapeutics, Inc. (NTLA) | Pacific Biosciences of Californ (PACB) |
|---|---|---|
| Current Price | $8.12 | $1.12 |
| Change | -0.16 (-1.93%) | -0.08 (-6.67%) |
| Market Cap | $0.84B | $0.34B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -1.47 | -1.65 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $28.18 | $2.72 |
| 52-Week Low | $5.90 | $1.06 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-5.25 | $-1.59 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| NTLA | 9.58% | -19.20% | -68.06% | -47.92% | -63.26% | -63.26% |
| PACB | -17.65% | -44.28% | -41.97% | -68.45% | -81.85% | -81.85% |